Trial intelligence / Profile preview

Lamotrigine Monotherapy in Pediatric Bipolar Disorder

NCT00176228Phase 2Completed

Sponsor
University of Illinois Chicago
Start
Feb 2004
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lamotrigine in bipolar disorder (BD), sponsored by University of Illinois Chicago. Started Feb 2004; status: completed.

02

Drugs

lamotrigine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00176228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00176228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call